Deferring Nail Mycological Sampling during the COVID-19 Pandemic: Recommendations from a Multidisciplinary Panel of Nail Specialists
Genre
Journal articleDate
2021-12-08Author
Lipner, Shari R.Ghannoum, Mahmoud
Hinshaw, Molly A.
Rich, Phoebe
Ruben, Beth S.
Vlahovic, Tracey

Scher, Richard K.
Department
Podiatric MedicineSubject
SARS-CoV-2COVID-19
Coronavirus
Pandemic
Onychomycosis
Fungal nail infection
Nail disease
Telemedicine
Nail clipping
Dermoscopy
Onychoscopy
Potassium hydroxide
Microscopy
Fungal culture
Polymerase chain reaction
Dermatology
Podiatry
Dermatopathology
Mycology
Permanent link to this record
http://hdl.handle.net/20.500.12613/7277
Metadata
Show full item recordDOI
https://doi.org/10.1159/000520628Abstract
Onychomycosis is the most common nail condition seen in clinical practice, with significant impact on quality of life. Clinical examination alone is insufficient for accurate diagnosis, but mycological confirmation can be challenging during the COVID-19 pandemic. In this letter, a multidisciplinary panel of dermatologists, a podiatrist, dermatopathologists, and a mycologist, discuss considerations for mycological sampling during the pandemic.Citation
Lipner SR, Ghannoum M, Hinshaw M, et al. Deferring Nail Mycological Sampling during the COVID-19 Pandemic: Recommendations from a Multidisciplinary Panel of Nail Specialists. Skin Appendage Disord. 2021. doi:10.1159/000520628Citation to related work
Karger PublishersHas part
Skin Appendange DisordersADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.eduae974a485f413a2113503eed53cd6c53
http://dx.doi.org/10.34944/dspace/7256